167 related articles for article (PubMed ID: 30992059)
1. DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis.
Shin Y; Ghate NB; Moon B; Park K; Lu W; An W
Epigenetics Chromatin; 2019 Apr; 12(1):25. PubMed ID: 30992059
[TBL] [Abstract][Full Text] [Related]
2. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis.
Kim K; Shin Y; Kim J; Ulmer TS; An W
Epigenetics Chromatin; 2018 May; 11(1):23. PubMed ID: 29807539
[TBL] [Abstract][Full Text] [Related]
3. MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis.
Kim K; Punj V; Kim JM; Lee S; Ulmer TS; Lu W; Rice JC; An W
Genes Dev; 2016 Jan; 30(2):208-19. PubMed ID: 26744418
[TBL] [Abstract][Full Text] [Related]
4. The MMP-2 histone H3 N-terminal tail protease is selectively targeted to the transcription start sites of active genes.
Weekley BH; Rice JC
Epigenetics Chromatin; 2023 May; 16(1):16. PubMed ID: 37161413
[TBL] [Abstract][Full Text] [Related]
5. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation.
Rice JC; Weekley BH; Kanholm T; Chen Z; Lee S; Fernandez DJ; Abrahamson R; Castaldi A; Borok Z; Dynlacht BD; An W
Epigenetics Chromatin; 2021 May; 14(1):23. PubMed ID: 34001241
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis.
Shin Y; Kim S; Ghate NB; Rhie SK; An W
Oncogene; 2022 Jan; 41(4):560-570. PubMed ID: 34785776
[TBL] [Abstract][Full Text] [Related]
7. MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis.
Shin Y; Kim S; Liang G; An W
Mol Oncol; 2024 Apr; ():. PubMed ID: 38600695
[TBL] [Abstract][Full Text] [Related]
8. Effect of dynamic DNA methylation and histone acetylation on cPouV expression in differentiation of chick embryonic germ cells.
Jiao F; Wang X; Yan Z; Liu C; Yue Z; Li Z; Ma Y; Li Y; Wang J
Stem Cells Dev; 2013 Oct; 22(20):2725-35. PubMed ID: 23750509
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
10. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage.
Kim Y; Kim J; Lee H; Shin WR; Lee S; Lee J; Park JI; Jhun BH; Kim YH; Yi SJ; Kim K
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430857
[TBL] [Abstract][Full Text] [Related]
12. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
[TBL] [Abstract][Full Text] [Related]
13. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
14. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA methyltransferases and histone deacetylases induces bone marrow-derived multipotent adult progenitor cells to differentiate into endothelial cells.
Mahapatra S; Firpo MT; Bacanamwo M
Ethn Dis; 2010; 20(1 Suppl 1):S1-60-4. PubMed ID: 20521387
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
18. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention.
Iliopoulos D; Malizos KN; Tsezou A
Ann Rheum Dis; 2007 Dec; 66(12):1616-21. PubMed ID: 17502362
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
